Enlivex Therapeutics Ltd. (ENLV.TA)

ILA 335.4

(1.45%)

Total Debt Summary of Enlivex Therapeutics Ltd.

  • Enlivex Therapeutics Ltd.'s latest annual total debt in 2023 was 1.03 Million USD , up 58.04% from previous year.
  • Enlivex Therapeutics Ltd.'s latest quarterly total debt in 2024 Q2 was 835 Thousand USD , down -10.02% from previous quarter.
  • Enlivex Therapeutics Ltd. reported annual total debt of 653 Thousand USD in 2022, up 5.83% from previous year.
  • Enlivex Therapeutics Ltd. reported annual total debt of 617 Thousand USD in 2021, up 203.94% from previous year.
  • Enlivex Therapeutics Ltd. reported quarterly total debt of 928 Thousand USD for 2024 Q1, down -10.08% from previous quarter.
  • Enlivex Therapeutics Ltd. reported quarterly total debt of 1.03 Million USD for 2023 FY, up 58.04% from previous quarter.

Annual Total Debt Chart of Enlivex Therapeutics Ltd. (2023 - 2012)

Historical Annual Total Debt of Enlivex Therapeutics Ltd. (2023 - 2012)

Year Total Debt Total Debt Growth
2023 1.03 Million USD 58.04%
2022 653 Thousand USD 5.83%
2021 617 Thousand USD 203.94%
2020 203 Thousand USD 65.04%
2019 123 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Total Debt Comparison of Enlivex Therapeutics Ltd.

Name Total Debt Total Debt Difference
Matricelf Ltd 1.24 Million ILA 16.908%